P3.01-021 Reproducibility of Comprehensive Histologic Assessment and Refining Histologic Criteria in P Staging of Multiple Tumor Nodules
Andrew Nicholson,Patrizia Viola,Kathleen Torkko,Edwina Duhig,Kim Geisinger,Alain Borczuk,Kenzo Hiroshima,Ming Tsao,Arne Warth,Sylvie Lantuejoul,Prudence Russell,Erik Thunnissen,Alberto Marchevsky,Mari Mino-Kenudson,Mary Beth Beasley,Johan Boding,Sanja Dacic,Yasushi Yatabe,Masayuki Noguchi,William Travis,Keith Kerr,Fred R. Hirsch,Lucian Chirieac,Ignacio Wistuba,Andre Moreira,Jin-Haeng Chung,Teh Ying Chou,Lukas Bubendorf,Gang Chen,Giuseppe Pelosi,Claudia Poleri,Wilbur Franklin
DOI: https://doi.org/10.1016/j.jtho.2016.11.1587
IF: 20.121
2017-01-01
Journal of Thoracic Oncology
Abstract:Multiple tumor nodules (MTNs) are being encountered, with increasing frequency with the 8th TNM staging system recommending classification as separate primary lung cancers (SPLC) or intrapulmonary metastases (IM). Pathological staging requires assessment of morphological features, with criteria of Martini and Melamed supplanted by comprehensive histologic assessment of tumor type, predominant pattern, other histologic patterns and cytologic features. With publication of the 2015 WHO classification of lung tumors, we assessed the reproducibility of comprehensive histologic assessment and also sought to identify the most useful histological features. We conducted an online survey in which pathologists reviewed a sequential cohort of resected multifocal tumors to determine whether they were SPLC, IM, or a combination. Specific histological features for each nodule were entered into the database by the observing pathologist (tumor type, predominant adenocarcinoma pattern, and histological features including presence of lepidic growth, intra-alveolar cell clusters, cell size, mitotic rate, nuclear pleomorphism, nucleolar size and pleomorphism, nuclear inclusions, necrosis pattern, vascular invasion, mucin content, keratinization, clear cell change, cytoplasmic granuleş lymphocytosis, macrophage response, acute inflammation and emperipolesis). Results were statistically analyzed for concordance with submitting diagnosis (gold standard) and among pathologists. Consistency of each feature was correlated with final determination of SPLC vs. IM status (p staging) by chi square analysis and Fisher exact test. Seventeen pathologists evaluated 126 tumors from 48 patients. Kappa score on overall assessment of primary v. metastatic status was 0.60. There was good agreement as measured by Cohen’s Kappa (0.64, p<0.0001) between WHO histological patterns in individual cases with SPLC or IM status but proportions for histology and SPT or IM status were not identical (McNemar's test, p<0.0001) and additional histological features were assessed. There was marked variation in p values among the specific histological features. The strongest correlations (<0.05) between p staging status and histological features were with nuclear pleomorphism, cell size, acinus formation, nucleolar size, mitotic rate, nuclear inclusions, intra-alveolar clusters and necrosis pattern. Correlation between lymphocytosis, mucin content, lepidic growth, vascular invasion, macrophage response, clear cell change, acute inflammation keratinization and emperipolesis did not reach a p value of 0.05. Comprehensive histologic assessment shows good reproducibility between practicing lung pathologists. In addition to main tumor type and predominant patterns, nuclear pleomorphism, cell size, acinus formation, nucleolar size, and mitotic rate appear to be useful in distinguishing between SPLC and IM.